We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

T Wave Alternans in Hemodialysis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00296543
Recruitment Status : Completed
First Posted : February 27, 2006
Last Update Posted : June 20, 2011
Information provided by:

February 23, 2006
February 27, 2006
June 20, 2011
October 2005
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00296543 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
T Wave Alternans in Hemodialysis
Pilot Study of a Noninvasive Predictor of Sudden Cardiac Death in Hemodialysis Patients
The purpose of this study is to determine if the hemodialysis procedure changes the risk for cardiac arrest in patients.
One-third to one-quarter of hemodialysis patients die of sudden cardiac death (SCD). The hemodialysis procedure may theoretically increase the risk of SCD. This study uses T wave alternans, a noninvasive marker of SCD, to objectively determine whether the hemodialysis procedure alters the risk of SCD in hemodialysis patients.
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Hemodialysis patients with heart disease and/or poor cardiac function
  • End Stage Renal Disease
  • Coronary Heart Disease
  • Congestive Heart Failure
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
August 2008
Not Provided

Inclusion Criteria:

  • 18 years of age or older
  • Normal sinus rhythm

Exclusion Criteria:

  • Inability to give written informed consent
  • Active cardiac ischemia
  • Pacemaker
  • Inability to perform a brief walking treadmill test
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
United States
Not Provided
Not Provided
Not Provided
Allon Friedman, MD, Indiana University School of Medicine
Indiana University School of Medicine
Dialysis Clinic, Inc.
Principal Investigator: Allon Friedman, MD Indiana University School of Medicine
Indiana University
June 2011